Page last updated: 2024-08-23

captopril and imipenem, anhydrous

captopril has been researched along with imipenem, anhydrous in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Brem, J; Cain, R; Fishwick, CW; Owens, RJ; Rydzik, AM; Salimraj, R; Schofield, CJ; Spencer, J; van Berkel, SS; Verma, A1
Brunst, S; Ducho, C; Frank, D; Haupenthal, J; Hirsch, AKH; Kramer, JS; Proschak, E; Rotter, M; Voos, K; Weizel, L; Wichelhaus, TA; Yahiaoui, S1
Arakawa, Y; Jin, W; Kimura, K; Kurosaki, H; Mori, S; Wachino, J; Yamaguchi, Y1

Other Studies

6 other study(ies) available for captopril and imipenem, anhydrous

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
Assay platform for clinically relevant metallo-β-lactamases.
    Journal of medicinal chemistry, 2013, Sep-12, Volume: 56, Issue:17

    Topics: beta-Lactamase Inhibitors; beta-Lactamases; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Mass Spectrometry; Metals

2013
    RSC medicinal chemistry, 2021, Oct-20, Volume: 12, Issue:10

    Topics:

2021
Structural Insights into Recognition of Hydrolyzed Carbapenems and Inhibitors by Subclass B3 Metallo-β-Lactamase SMB-1.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; beta-Lactamases; Captopril; Carbapenems; Catalytic Domain; Crystallography, X-Ray; Doripenem; Imipenem; Meropenem; Mesna; Protein Structure, Secondary; Protein Structure, Tertiary; Serratia marcescens; Thienamycins

2016